MF
VRTX icon

Manchester Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Manchester Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 640
2021
Q1 		$0 Sell
1
-1
-50% -$220 ﹤0.01% 777
2020
Q4 		$0 Sell
2
-100
-98% -$22.9K ﹤0.01% 659
2020
Q3 		$28K Hold
102
– – 0.02% 198
2020
Q2 		$30K Buy
+102
New +$27.7K 0.02% 182

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Manchester Financial's VRTX Position: Q2 2021 in Review

Manchester Financial sold out of Vertex Pharmaceuticals (VRTX) in Q2 2021, closing a stake of 1 share.

Manchester Financial first reported a position in VRTX in Q2 2020 and held it in 4 quarters. The position peaked at $30K in Q2 2020. 977 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.

  • Manchester Financial reported no remaining Vertex Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 1 Vertex Pharmaceuticals share in Q2 2021.
  • Manchester Financial first reported a position in Vertex Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Manchester Financial's Vertex Pharmaceuticals position peaked at $30K in Q2 2020.
  • 977 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.